Insulin and Insulin-Like Growth Factor (Somatomedin) Receptors on Cloned Rat Pituitary Tumor Cells*
- 1 November 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 117 (5) , 2008-2016
- https://doi.org/10.1210/endo-117-5-2008
Abstract
Specific receptors for insulin and the somatomedin peptides insulin-like growth factors I and II (IGF-I and IGF-II) have been characterized on three separate cloned strains of rat pituitary tumor cells (GH3, GH1, and GC). Binding of 125I-labeled peptides was time, temperature, and pH dependent for all three cell lines. Specific binding of [125I]insulin, which was extremely low in normal rat adenohypophyseal cells, was demonstrable for all three lines, with the Kd for the high affinity receptor ranging from 10-10 to 4 .times. 10-10 M/liter. A specific high affinity IGF-I receptor was also identified, with a Kd of approximately 10-9 M/liter. IGF-II and insulin were, respectively, 10% and 1% as potent as IGF-I in competing for this receptor. When [125I]insulin and [125I]IGF-I were cross-linked to GH3 cells with disuccinimidyl suberate, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, both receptors were found to have an apparent mol wt greater than 300,000 in the unreduced state, with subunits of apparent mol wt 125,000 after reduction. A third discrete receptor, which bound [125I]IGF-II, was also identified on all three cell lines. IGF-I was only 10% as potent as IGF-II at displacing [125I]IGF-II, and insulin was virtually unreactive. When [125I]IGF-II was cross-linked to GH3 cells and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, two receptors were identified. One had an apparent mol wt of 205,000 unreduced and 250,000 upon reduction, and presumably represents the type II receptor. Additionally, a band was observed at an apparent mol wt greater than 300,000 unreduced and 125,000 upon reduction, probably representing IGF-II binding to the IGF-I or insulin receptor. The presence of specific high affinity receptors for insulin, IGF-I, and IGF-II in these transformed cell lines is consistent with previous observations in normal rat and human pituitary cells and suggests a role for these peptides in the modulation of pituitary function.This publication has 27 references indexed in Scilit:
- Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferationThe Journal of cell biology, 1980
- Induction of Immunoreactive Somatomedin C in Human Serum by Growth Hormone: Dose-Response Relationships and Effect on Chromatographic Profiles*Journal of Clinical Endocrinology & Metabolism, 1980
- Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from the mitogenic response.Proceedings of the National Academy of Sciences, 1980
- Increased Somatomedin Receptor Sites in Newborn Circulating Mononuclear Cells*Journal of Clinical Endocrinology & Metabolism, 1979
- Control of growth hormone synthesis in cultured GH1 cells by 3,5,3'-triiodo-L-thyronine and glucocorticoid agonists and antagonists: studies on the independent and synergistic regulation of the growth hormone responseBiochemistry, 1979
- Characterization of functional receptors for somatostatin in rat pituitary cells in culture.Journal of Biological Chemistry, 1978
- The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.Journal of Biological Chemistry, 1978
- Glucocorticoid induction of growth hormone synthesis in a strain of rat pituitary cells.Journal of Biological Chemistry, 1977
- Regulation of growth hormone messenger RNA by thyroid and glucocorticoid hormones.Proceedings of the National Academy of Sciences, 1977
- Establishment of Clonal Strains of Rat Pituitary Tumor Cells That Secrete Growth Hormone1,2Endocrinology, 1968